Avid Bioservices Inc (CDMO)

[biopharm]

Scott Antonia : Peregrine Pharmaceuticals KOL :

.... my goal is to map out every KOL and their affiliations and ties. If a landscaper is intrigued by Fargo events and PS Targeting, I would imagine that all the Doctors associated with KOL's... well many of them, would naturally be curious why all the focus on PS Targeting at this time with Peregrine Pharmaceuticals.. right?

Big Pharma can't pay off everyone, because everyone knows someone that is affected by cancer, and the best treatment decision must be decided upon. I say it involves PS Targeting.

-----------------------------------------------------------

Center for Infection Research in Cancer (CIRC)

Director: Anna R. Giuliano, PhD

Members:

Claudio Anasetti, MD
Scott J. Antonia, MD, PhD
Christine M. Pierce Campbell, PhD, MPH
W. Douglas Cress, PhD
Ellen M. Daley, PhD
Kristine A. Donovan, PhD, MBA
Peter A. Forsyth, MD
Robert A. Gatenby, MD
Geoffrey T. Gibney, MD
Robert J. Gillies, PhD
Anna R. Giuliano, PhD
Eric B. Haura, MD
Johnathan Mark Lancaster, MD, PhD
Christine Laronga, MD, FACS
Marino E. Leon, MD
Hui-Yi Lin, PhD
Anthony M. Magliocco, MD
Volker Mai, PhD, MPH
Peter G. Medveczky, MD
Lynette J. Menezes, PhD
Jane L. Messina, MD
Alvaro NA Monteiro, PhD
James J. Mule, PhD
Teresita Munoz-Antonia, PhD
Catherine M. Phelan, PhD, MD, MMS
Julio M. Pow-Sang, MD
Lary Allen Robinson, MD
Richard G. Roetzheim, MD, MSPH
Dana E. Rollison, PhD
Matthew B. Schabath, PhD
Ed Seto, PhD
David Shibata, MD
Erin M. Siegel, PhD, MPH
Lubomir Sokol, MD, PhD
Philippe E. Spiess, MD

http://moffitt.org/research--clinical-trials/research-disciplines/centers-of-excellence/center-for-infection-research-in-cancer


CIRC External Advisory Board: (to be announced)

http://moffitt.org/research--clinical-trials/research-disciplines/centers-of-excellence/circ-external-advisory-board
----------------------------------------------------------